TP53 and breast cancer: On the one hand, faster epigenetic age was observed in tumors carrying a smaller number of somatic mutations, tumors with TP53 mutations, acute myeloid leukemia, hormone receptor-positive (luminal type) breast cancer, and BRAF-positive colorectal cancer [24, 50].